The Role of the Pharmacist in Managing Type 2 Diabetes with Glucagon-Like Peptide-1 Receptor Agonists as Add-On Therapy

Feb 18, 2017Advances in therapy

Pharmacists’ role in managing type 2 diabetes using added GLP-1 receptor agonist treatment

AI simplified

GLP-1 Therapies on OpenScience ↗PubMed ↗DOI ↗

Abstract

GLP-1 receptor agonists (GLP-1RAs) may improve glycemic control in adults with type 2 diabetes (T2D) without increasing the risk of hypoglycemia.

GLP-1RAs are injectable agents that work alongside diet and exercise to manage T2D.
These medications can lower glucose levels, slow gastric emptying, enhance feelings of fullness, and reduce body weight.
Approved GLP-1RAs in the USA include exenatide, liraglutide, albiglutide, and dulaglutide.
Pharmacists can collaborate with physicians to determine suitable candidates for GLP-1RA therapy.
Patient education by pharmacists includes guidance on medication storage, injection techniques, and monitoring blood glucose levels.

AI simplified

UNLABELLED: The prevalence and associated clinical burden of type 2 diabetes (T2D) is increasing in the USA and other countries. As a consequence, the role of the pharmacist in managing T2D is expanding, and it is becoming increasingly important for pharmacists to have a complete understanding of the disease course and treatment options. Pharmacists have a key role in the use of injectable therapies, including incretin-based treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs). This article discusses the role of the pharmacist in the management of patients with T2D, particularly with respect to the use of GLP-1RAs to achieve glycemic control. GLP-1RAs are a class of injectable agents used as an adjunct to diet and exercise to improve glycemic control in adults with T2D. GLP-1RAs have been shown to lower glucose levels, slow gastric emptying, enhance satiety, and reduce body weight without increasing the risk of hypoglycemia. GLP-1RAs currently approved in the USA include exenatide twice daily, liraglutide once daily, and albiglutide, dulaglutide, and exenatide once weekly. Pharmacists can work with physicians to help identify patients for whom GLP-1RA therapy is appropriate. In addition, pharmacists can educate patients regarding medication storage, preparation, and injection techniques, glycated hemoglobin (HbA) targets, pre- and post-meal blood glucose goals, adverse events and management strategies, and the long-term benefits of reducing HbA. As members of the diabetes care team, pharmacists play an important role in improving patient outcomes. 1c1c

FUNDING: AstraZeneca.

Full Text

Full text is available at the source.

View full text (PDF) ↗View full text (HTML) ↗

The Role of the Pharmacist in Managing Type 2 Diabetes with Glucagon-Like Peptide-1 Receptor Agonists as Add-On Therapy

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the glp-1 therapies brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the glp-1 therapies brief